Pages that link to "Q67822447"

The following pages link to In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II (Q67822447):

Displaying 23 items.

• Computational lipidology: predicting lipoprotein density profiles in human blood plasma (Q28472676) (← links)
• Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis (Q28645882) (← links)
• Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. (Q33849302) (← links)
• Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency (Q33903940) (← links)
• Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease (Q34120460) (← links)
• Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein (Q34172240) (← links)
• A unique genetic and biochemical presentation of fish-eye disease (Q34386276) (← links)
• High-density-lipoprotein cholesterol and atherosclerosis (Q34707124) (← links)
• The concept of apolipoprotein-defined lipoprotein families and its clinical significance (Q35549917) (← links)
• Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. (Q35609905) (← links)
• Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism (Q35763106) (← links)
• Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice (Q35824669) (← links)
• Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome (Q37311118) (← links)
• Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner (Q37354180) (← links)
• Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II). (Q37401325) (← links)
• A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels (Q38616263) (← links)
• Speciated High-Density Lipoprotein Biogenesis and Functionality. (Q38785650) (← links)
• Physical activity and lipoprotein lipid disorders (Q40737304) (← links)
• Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters (Q42809345) (← links)
• Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods (Q44464581) (← links)
• Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1. (Q51017649) (← links)
• [Laboratory diagnosis in preventive cardiology] (Q74639192) (← links)
• Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies (Q90666652) (← links)